Skincare empire Bwx has stunned the market with news it has paused trade in its shares just before it was scheduled to release its full-year results.
The Andrew-Forrest backed company said it needed more time to prepare its final financial accounts after flagging some revenue recognition issues from the previous two years that could lead to it falling short of full-year guidance.
Bwx said it expected its voluntary suspension to end on the completion of its Appendix 4E and fully audited accounts by September 30.
Bwx shares are frozen at 63 cents apiece.